North America

Fri
17
May

The 3 best marijuana stocks to buy right now

Since their inception, marijuana stocks attracted significant attention. Due to both investment sentiment – and let’s face it, raw emotions – the cannabis sector absolutely skyrocketed. But now, the segment is attracting attention for failing to live up to analysts’ expectations. Is the honeymoon phase over for weed?

Hardly! While cannabis firms have produced some disappointing results during earnings season, that’s no reason to abandon them. For one thing, the resurgent U.S.-China trade war is incredibly favorable for marijuana stocks to buy. Prolonged tensions will almost surely cause us economic damage. An easy fix here is to legalize weed and fully open the door to a multi-billion dollar industry.

Fri
17
May

How do cannabis and alcohol mix? Studies show it can get dangerous

With springtime here and winter behind us, many might be getting in the party mood, to stretch out their legs and hit the town.

As we all know, part of the festivities may include certain substances, two of them likely cannabis and alcohol.

On a night out at a bar, chances are high that at some point somebody will whip out a joint.

According to Public Health Ontario, combined use of cannabis and alcohol is the most common form of poly-substance use.

But what exactly happens when the two substances are combined?

Fri
17
May

From the farm to the lab: The future of cannabinoid production

In the near future, cannabis consumers and medical patients will very likely find themselves purchasing cannabis products that were not derived from the marijuana plant. Instead, the cannabinoids could be derived from yeast, gene graphing, or even moss. If all the quality control, consumer safety, and satisfaction boxes get checked, does the source of the cannabinoids really matter?

Thu
16
May

Most health professionals supportive of the use of medical cannabis in clinical practice per study

The majority of health professionals — including doctors, nurses, and pharmacists — express support the use of medical cannabis in clinical practice, according to a systematic review of the relevant literature published in the journal PLOS One.

An international team of investigators reviewed over 100 studies assessing health professionals’ opinions with regard to medical cannabis.

Thu
16
May

The State of cannabis extracts

I’ll never forget the first time I tried shatter, back in 2008. As the mind-shatteringly potent high took hold, I felt certain we had reached the final destination of cannabis. Here was the ultimate expression of the plant that consumers had been relishing for years. Shatter was the holy grail, it seemed. For cannabis, there was nowhere else to go. I was wrong. 

Thu
16
May

Highly potent weed has swept the market, raising concerns about health risks

As more states legalize marijuana, more people in the U.S. are buying and using weed — and the kind of weed they can buy has become much stronger.

That concerns scientists who study marijuana and its effects on the body, as well as emergency room doctors who say they're starting to see more patients who come into the ER with weed-associated issues.

Thu
16
May

What’s the real link between pot dispensaries and crime rates?

For years, opponents of marijuana legalization have voiced the same arguments whenever the subject of dispensaries comes up: having legal cannabis vendors, they say, promotes the spread of crime, brings property values down in the neighborhood and encourages teenage marijuana use. And even though the push for marijuana legalization has gained widespread national support, these arguments against dispensaries have held sway.

Thu
16
May

How New Frontier Data brings analytics to cannabis

How one woman’s vision is bringing data-driven solutions to a global market.

The legal cannabis industry is rapidly expanding across the U.S. In fact, it generated more than $8 billion in 2017 and is expected to surpass $23 billion by 2025, according to a 2018 industry report. This is critical information for investors, operators, and policymakers involved in the sector. Further, it’s information that is only available thanks to the rigorous studies conducted and compiled by New Frontier Data (NFD), an independent, technology-driven analytics company.

Thu
16
May

Aurora Cannabis sold 9 tons of marijuana last quarter

Aurora Cannabis sold a ton of weed last quarter. Nine metric tons, in fact.

Like the other Canadian pot producers reporting earnings Tuesday, Aurora increased sales strongly in its March quarter. Investors had worried that the recreational marijuana market was off to a slow start in Canada, but on Tuesday evening the Edmonton, Alberta-based Aurora Cannabis reported that its net revenue grew 20% from the December period, to reach 65 million Canadian dollars (or US$48.5 million) for the March period. Aurora’s recreational sales grew 37% sequentially.

Thu
16
May

Big box retailers are eyeing CBD from afar

Following in Walmart’s footsteps, multiple large chain stores are prepping for the inevitable day that CBD products will be filling their shelves.

A few weeks ago, Walmart signed a deal with New Age Beverages and, love them or hate them, Walmart has always been good at staying ahead of the trends. Now, other big box retailers are taking heed and working on securing their own contracts for CBD products. Some of these companies include Target, Kroger, and Safeway.

Pages

Subscribe to RSS - North America